Predictors of treatment response and overall survival in patients with breast cancer brain metastases treated with stereotactic radiosurgery: a prospective study using the NeuroPoint Alliance SRS Registry

Using real-world data from the NPA SRS Registry, this study demonstrated comparable outcomes in patients who underwent SRS for breast cancer brain metastases compared with those of previous literature. The number of lesions at the time of SRS and the marginal dose were independent risk factors for local recurrence, out-of-field progression, and overall intracranial progression. Pre-SRS resection and baseline EQ-5D score were independent predictors of quality of life following SRS.

Authors

Institutions

Publication Details

Journal
Journal of neurosurgery
Published
2025-06-27
DOI
https://doi.org/10.3171/2025.3.jns241471
Primary Topic
Brain Metastases and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Predictors of treatment response and overall survival in patients with breast cancer brain metastases treated with stereotactic radiosurgery: a prospective study using the NeuroPoint Alliance SRS Registry

Nader Pouratian, Konstantinos Katsos, Mohamad Bydon, Jason P. Sheehan et al.
Journal of neurosurgery
Brain Metastases and Treatment
article

Predictors of treatment response and overall survival in patients with breast cancer brain metastases treated with stereotactic radiosurgery: a prospective study using the NeuroPoint Alliance SRS Registry

Nader Pouratian, Konstantinos Katsos, Mohamad Bydon, Jason P. Sheehan, Eric L. Chang, David W. Andrews, Robert Timmerman, Randy L. Jensen, James McInerney, Kevin A. Walter, Giorgos D. Michalopoulos, Anthony L. Asher, Anthony D’Ambrosio, Albert Attia, William S. Cobb, Aaron C. Spalding, Inga S. Grills
article en

Abstract

Using real-world data from the NPA SRS Registry, this study demonstrated comparable outcomes in patients who underwent SRS for breast cancer brain metastases compared with those of previous literature. The number of lesions at the time of SRS and the marginal dose were independent risk factors for local recurrence, out-of-field progression, and overall intracranial progression. Pre-SRS resection and baseline EQ-5D score were independent predictors of quality of life following SRS.

Journal of neurosurgeryVol. 143(5)
University of Southern California (US), Mayo Clinic (US), Carolinas Healthcare System (US), Lebanon Valley College (US), Norton Healthcare (US), University of Utah (US), Thomas Jefferson University Hospital (US), Beaumont Health (US), University of Virginia Health System (US), Valley Hospital (US), Jacksonville College (US), University of Rochester Medical Center (US), Carolina Neurosurgery and Spine Associates (US), Southwestern Medical Center (US), Mayo Clinic in Florida (US), Neurological Surgery (US), Southwestern Medical Center (US), Penn State Milton S. Hershey Medical Center (US), The University of Texas Southwestern Medical Center (US)
Good health and well-being
Openalex Percentile: Top 75%
Brain Metastases and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.